MDSC: Small Molecule Oral Signaling Inhibitors Icariin and Icaritin Targeting CD33+ MDSC in MDS

FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICE

Contact

Charlie Shaw PhD
Associate Director, Patents & Licensing
Charlie.Shaw@Moffitt.org
(813) 745-6639

14MA005N